SCHEMBL7673154

SCHEMBL7673154

COc1cc(F)ccc1C[O]

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
KDM4E B2RXH2 3/20 0.42
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
ALDH1A1 P00352 2/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
POLB P06746 1/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
FFAR1 O14842 1/20 0.40
FFAR4 Q5NUL3 1/20 0.40
USP2 O75604 1/20 0.40
APLNR P35414 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8342657 0.86 KDM4E (0.47) HDAC3HDAC1HDAC2HDAC6KDM4E
SCHEMBL7661925 0.86 ALDH1A1 (0.49) KDM4EGAAALDH1A1KMT2AMEN1
SCHEMBL696497 0.80 PDCD1 (0.50) HDAC3HDAC1HDAC2HDAC6KDM4E
SCHEMBL31280496 0.80 HDAC3 (0.43) HDAC3HDAC1HDAC2HDAC6KDM4E
SCHEMBL2425944 0.80 GAA (0.46) HDAC3HDAC1HDAC2HDAC6GAA
SCHEMBL1941479 0.80 HDAC3 (0.43) HDAC3HDAC1HDAC2HDAC6KDM4E
SCHEMBL31280042 0.80 PDCD1 (0.50) HDAC3HDAC1HDAC2HDAC6KDM4E
SCHEMBL4434656 0.79 ALDH1A1 (0.44) HDAC3HDAC1HDAC2HDAC6KDM4E
SCHEMBL29531337 0.79 ALDH1A1 (0.44) HDAC3HDAC1HDAC2HDAC6KDM4E
SCHEMBL20560055 0.79 HDAC3 (0.43) HDAC3HDAC1HDAC2HDAC6KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101072561-A Diaminoalkane aspartic protease inhibitors VITAE PHARMACEUTICALS INC (US) 2007-11-14 CN claimed
US-6476021-B1 Compounds having cGMP-PDE inhibitory effect MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2002-11-05 US disclosed
CN-1284075-A Novel compounds having CGMP-PDE inhibitory effect MOCHIDA PHARM CO LTD (JP) 2001-02-14 CN disclosed
EP-1048666-A1 NOVEL COMPOUNDS HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-11-02 EP disclosed